Abstract:Background Bleomycin is a broad-spectrum glycopeptide antitumor antibiotic produced by Streptomyces verticillus . Clinically, the mixture of bleomycin A2 and bleomycin B2 is widely used in combination with other drugs for the treatment of various cancers. As a secondary metabolite, the biosynthesis of bleomycin is precisely controlled by the complex extra-/intracellular regulation mechanisms, it is imperative to investigate the global metabolic and regulatory system involved in bleomycin biosynthesis for increasing bleomycin production. Results N -acetylglucosamine (GlcNAc), the vital signaling molecule controlling the onset of development and antibiotic synthesis in Streptomyces , was found to increase the yields of bleomycins significantly in chemically defined medium. To mine the gene information relevant to GlcNAc metabolism, the DNA sequences of dasR - dasA - dasBCD - nagB and nagKA in S. verticillus were determined by chromosome walking. From the results of Real time fluorescence quantitative PCR (RT-qPCR) and electrophoretic mobility shift assays (EMSAs), the repression of the expression of nagB and nagKA by the global regulator DasR was released under induction with GlcNAc. The relief of blmT expression repression by BlmR was the main reason for increased bleomycin production. DasR, however, could not directly affect the expression of the pathway-specific repressor BlmR in the bleomycins gene cluster. With at the beginning of bleomycin synthesis, the supply of the specific precursor GDP-mannose played the key role in bleomycin production. Genetic engineering of the GDP-mannose synthesis pathway indicated that phosphomannose isomerase (ManA) and phosphomannomutase (ManB) were key enzymes for bleomycins synthesis. Here, the blmT , manA and manB co-expression strain OBlmT/ManAB was constructed. Based on GlcNAc regulation and assisted metabolic profiling analysis, the yields of bleomycin A2 and B2 were ultimately increased to 61.79 and 36.9 mg/L, respectively. Conclusions Under GlcNAc induction, the elevated production of bleomycins was mainly associated with the alleviation of the inhibition of BlmT, so blmT and specific precursor synthesis pathways were genetically engineered for bleomycins production improvement. Combination with subsequent metabolomics analysis not only effectively increased the bleomycin yield, but also extended the utilization of chitin-derived substrates in microbial-based antibiotic production.

Engineering of Glarea lozoyensis for exclusive production of the pneumocandin B0 precursor of the antifungal drug caspofungin acetate.

Genomics-driven Discovery of the Pneumocandin Biosynthetic Gene Cluster in the Fungus Glarea Lozoyensis

Engineering of New Pneumocandin Side-Chain Analogues from Glarea Lozoyensis by Mutasynthesis and Evaluation of Their Antifungal Activity.

Exploration of the pneumocandin biosynthetic gene cluster based on efficient CRISPR/Cas9 gene editing strategy in Glarea lozoyensis

Novel Osmotic Stress Control Strategy for Improved Pneumocandin B0 Production in Glarea Lozoyensis Combined with a Mechanistic Analysis at the Transcriptome Level.

Enhancement of Pneumocandin B0 Production in Glarea Lozoyensis by Low-Temperature Adaptive Laboratory Evolution

Genetic Manipulation of the Pneumocandin Biosynthetic Pathway for Generation of Analogues and Evaluation of Their Antifungal Activity.

Effect of fatty acids on intracellular pneumocandin B0 storage in the fermentation of Glarea lozoyensis

Unnatural Tetradeoxy Echinocandins Produced by Gene Cluster Design and Heterologous Expression.

Reanalysis of the Mitochondrial Genome of the Pneumocandin-Producing Fungus Glarea Lozoyensis

Analysis of FR901379 Biosynthetic Genes in <i>Coleophoma empetri</i> by Clustered Regularly Interspaced Short Palindromic Repeats/Cas9-Based Genomic Manipulation

Analysis of FR901379 Biosynthetic Genes in Coleophoma empetri by Clustered Regularly Interspaced Short Palindromic Repeats/Cas9-Based Genomic Manipulation

Establishing an Efficient Genetic Manipulation System for Sulfated Echinocandin Producing Fungus Coleophoma Empetri

Selective transformation of crocin-1 to crocetin-glucosyl esters by β-glucosidase (Lf18920) from Leifsonia sp. ZF2019: Insights from molecular docking and point mutations

Engineering Validamycin Production by Tandem Deletion of Γ-Butyrolactone Receptor Genes in Streptomyces Hygroscopicus 5008

Efficient Bioconversion of Echinocandin B to Its Nucleus by Overexpression of Deacylase Genes in Different Host Strains.

Metabolomics Profiling Reveals the Mechanism of Increased Pneumocandin B0 Production by Comparing Mutant and Parent Strains

A Cell Factory of a Fungicolous Fungus Calcarisporium arbuscula for Efficient Production of Natural Products

Enhanced amphotericin B production by genetically engineered Streptomyces nodosus

Effects of Cotton Seed Powder As the Seed Medium Nitrogen Source on the Morphology and Pneumocandin B0 Yield of Glarea Lozoyensis

Enhancement of Bleomycin Production in Streptomyces Verticillus Through Global Metabolic Regulation of N -Acetylglucosamine and Assisted Metabolic Profiling Analysis